600129.SH
太极集团
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 14.21
−5.71%Forward multiples
Based on analyst estimates
- P/E forward
- 6.42x
- P/E 2026E
- 27.60x
- P/E 2027E
- 14.84x
- P/E 2028E
- 11.60x
- P/S forward
- 0.52x
Trailing multiples
Trailing twelve months
- P/E TTM
- 64.99x
- PEG TTM
- 0.07x
- Price / book
- 2.20x
- Price / sales
- 0.75x
- Price / cash flow
- 21.93x
Enterprise value
- Enterprise value
- CNY 12.3B
- EV / sales
- 1.21x
- EV / EBITDA
- 19.47x
- EV / EBIT
- 54.80x
- Market cap
- CNY 7.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026